Capreomycin Sulfate is the sulfate salt of Capreomycin, a broad-spectrum, cyclic peptide antiphlogistic antibiotic often grouped with the aminoglycosides. The product is a mixture of 1A and 1B forms. It can be used to study bacterial ribosomes and protein synthesis. It is bacteriostatic but can also be used to study multidrug-resistant tuberculosis. It was discovered from Streptomyces capreolus in 1960, with FDA filing by Eli Lilly in the US in 1971.
Capremycin Sulfate is freely soluble in water.
